SCHEMBL2433151

SCHEMBL2433151

COC(=O)[C@H]1CC[C@H](OC(F)(C(=O)Cc2ccc(NC(=O)c3nn(C)c4ccccc34)c(Cl)c2)N2CCCC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.42
ITGB1 P05556 6/20 0.41
ITGA4 P13612 6/20 0.41
HTR3A P46098 2/20 0.37
OPRK1 P41145 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CRHR1 P34998 1/20 0.36
HTR3E A5X5Y0 1/20 0.35
SLC22A2 O15244 1/20 0.35
HTR3B O95264 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
KCNH2 Q12809 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
SLC47A1 Q96FL8 1/20 0.35
RBP4 P02753 1/20 0.35
LCK P06239 2/20 0.35
CSK P41240 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2433155 1.00 KDM1A (0.42) KDM1AITGB1ITGA4HTR3AOPRK1
SCHEMBL2437864 0.94 ITGB1 (0.47) KDM1AITGB1ITGA4HTR3AKDM4E
SCHEMBL2437861 0.94 ITGB1 (0.47) KDM1AITGB1ITGA4HTR3AKDM4E
SCHEMBL2432107 0.89 ITGB1 (0.45) KDM1AITGB1ITGA4HTR3AKDM4E
SCHEMBL2432104 0.89 ITGB1 (0.45) KDM1AITGB1ITGA4HTR3AKDM4E
SCHEMBL2433766 0.87 ITGB1 (0.54) KDM1AITGB1ITGA4OPRK1
SCHEMBL2436020 0.87 ITGB1 (0.54) ITGB1ITGA4OPRK1CHRNB2CHRNA4
SCHEMBL2436019 0.87 ITGB1 (0.54) ITGB1ITGA4OPRK1CHRNB2CHRNA4
SCHEMBL2433946 0.85 ITGB1 (0.57) ITGB1ITGA4
SCHEMBL2433948 0.85 ITGB1 (0.57) ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346982-B1 VLA-4 INHIBITORS DAIICHI SEIYAKU CO (JP) 2011-09-14 EP disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
US-20040110945-A1 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
EP-1346982-A1 VLA-4 INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110945-A1 Vla-4 inhibitors VCAM1, ITGA1, ITGB4 KDM1A 816/4885ITGB1 5/4885ITGA4 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.